Since the beginning of the COVID-19 pandemic, PCR assays have been the gold standard for detecting SARS-CoV-2. Mammoth Biosciences (CA, USA) is developing a CRISPR-based diagnostic workflow that aims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback